You are viewing an incomplete version of our website. Please click to reload the website as full version.

Calpain 3 antibody (CAPN3) (C-Term)

Details for Product anti-CAPN3 Antibody No. ABIN965743, Supplier: Login to see New
Request Want additional data for this product?

The Independent Validation Initiative strives to provide you with high quality data. Find out more

Synonyms capn3, MGC80925, zgc:92687, CAPN3, AI323605, Capa-3, Capa3, Lp82, p94, Lp84, Lp85, CANP3, CANPL3, LGMD2, LGMD2A, nCL-1, SKM-CALP, SKM-CALPOV, nCL1
(7), (3), (2), (2), (2), (2), (1), (1), (1), (1), (1), (1)
(30), (8), (7), (3), (2), (2), (2)
(27), (3)
This Calpain 3 antibody is un-conjugated
Immunohistochemistry (IHC)
(24), (11), (8), (5), (4), (3), (2), (1)
Pubmed 8 references available
Supplier Login to see New
Catalog number from supplier Login to see New
Quantity 0.1 mg
Shipping to United States ( )
Availability Will be delivered in 5 to 7 Business Days
Immunogen Polyclonal antibody produced in rabbits immunizing with a synthetic peptide corresponding to C-terminal residues of human CAPN3(Calpain-3)
Purification Purified by antigen-specific affinity chromatography.
Alternative Name CAPN3 (CAPN3 Antibody Abstract)
Background CAPN3(Calpain-3) is a calcium-regulated non-lysosomal thiol-protease. It has a broad endopeptidase specificity. CAPN3 is activated by micromolar concentrations of calcium and inhibited by calpastatin. It interacts with TTN/titin. Isoform I is skeletal muscle specific. Defects in CAPN3 are the cause of limb-girdle muscular dystrophy type 2A (LGMD2A). LGMD2A is both autosomal dominantly and recessively transmitted. It is characterized by progressive symmetrical atrophy and weakness of the proximal limb muscles and elevated serum creatine kinase. CAPN3 belongs to the peptidase C2 family and contains 1 calpain catalytic domain and 4 EF-hand domains.
Application Notes ELISA, Western blotting: 1µg/ml for 2hrs.
Restrictions For Research Use only
Format Liquid
Buffer This antibody is stored in PBS, 50% glycerol
Preservative Sodium azide
Precaution of Use This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage -20 °C
Background publications Miller, Bang, Witt et al.: "The muscle ankyrin repeat proteins: CARP, ankrd2/Arpp and DARP as a family of titin filament-based stress response molecules." in: Journal of molecular biology, Vol. 333, Issue 5, pp. 951-64, 2003 (PubMed).

Richard, Roudaut, Saenz et al.: "Calpainopathy-a survey of mutations and polymorphisms. ..." in: American journal of human genetics, Vol. 64, Issue 6, pp. 1524-40, 1999 (PubMed).

Urtasun, Sáenz, Roudaut et al.: "Limb-girdle muscular dystrophy in Guipúzcoa (Basque Country, Spain)." in: Brain : a journal of neurology, Vol. 121 ( Pt 9), pp. 1735-47, 1998 (PubMed).

Dinçer, Leturcq, Richard et al.: "A biochemical, genetic, and clinical survey of autosomal recessive limb girdle muscular dystrophies in Turkey." in: Annals of neurology, Vol. 42, Issue 2, pp. 222-9, 1997 (PubMed).

Richard, Brenguier, Dinçer et al.: "Multiple independent molecular etiology for limb-girdle muscular dystrophy type 2A patients from various geographical origins." in: American journal of human genetics, Vol. 60, Issue 5, pp. 1128-38, 1997 (PubMed).

Fardeau, Hillaire, Mignard et al.: "Juvenile limb-girdle muscular dystrophy. Clinical, histopathological and genetic data from a small community living in the Reunion Island." in: Brain : a journal of neurology, Vol. 119 ( Pt 1), pp. 295-308, 1996 (PubMed).

Richard, Broux, Allamand et al.: "Mutations in the proteolytic enzyme calpain 3 cause limb-girdle muscular dystrophy type 2A." in: Cell, Vol. 81, Issue 1, pp. 27-40, 1995 (PubMed).

Sorimachi, Imajoh-Ohmi, Emori et al.: "Molecular cloning of a novel mammalian calcium-dependent protease distinct from both m- and mu-types. Specific expression of the mRNA in skeletal muscle." in: The Journal of biological chemistry, Vol. 264, Issue 33, pp. 20106-11, 1989 (PubMed).

Catalog No. ABIN965743
Plus shipping costs $45.00

Order hotline:

  • +1 877 302 8632
  • +1 888 205 9894 (TF)